Acinetobacter: A potential reservoir and dispenser for β-lactamases

Critical Reviews in Microbiology

Volumn 38, Issue 1, 2012, Pages 30-51

  Zhao, Wei Hua ^a   Hu, Zhi Qing ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acinetobacter; Acinetobacter derived cephalosporinase (ADC); Carbapenem hydrolysing class D lactamase (CHDL); Insertion sequence (IS); Integron

Indexed keywords

AMINO ACID; AMINOGLYCOSIDE; AMPICILLIN; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; CHLORAMPHENICOL; QUINOLONE DERIVATIVE;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER INFECTION; ACINETOBACTER JOHNSONII; ACINETOBACTER LWOFFII; ACINETOBACTER NOSOCOMIALIS; ACINETOBACTER PITTII; ACINETOBACTER RADIORESISTENS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD; CATHETER; ENDOCARDITIS; ENDOPHTHALMITIS; GENE EXPRESSION; GENE INSERTION SEQUENCE; HOSPITAL INFECTION; HUMAN; INTEGRON; KERATITIS; MENINGITIS; MICROBIOLOGY; MUCOSA; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHYLOGENY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RESERVOIR; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION; REVIEW; SKIN; TAXONOMY; UNINDEXED SEQUENCE; URINARY TRACT; URINARY TRACT INFECTION; WOUND;

ACINETOBACTER; ACINETOBACTER INFECTIONS; BACTERIAL PROTEINS; BETA-LACTAMASES; HUMANS; INTEGRONS;

ACINETOBACTER; ACINETOBACTER BAUMANNII;

EID: 84855867095     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2011.621064     Document Type: Review

References (177)

1. Afzal-Shah M, Woodford N, Livermore DM. (2001). Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother, 45, 583-588. (Pubitemid 32105297)
2. Alsultan AA, Hamouda A, Evans BA, Amyes SG. (2009). Acinetobacter baumannii: emergence of four strains with novel blaOXA-51-like genes in patients with diabetes mellitus. J Chemother, 21, 290-295.
3. Ambler RP. (1980). The structure of β-lactamases. Philos Trans R Soc Lond, B, Biol Sci, 289, 321-331.
4. Anandham R, Weon HY, Kim SJ, Kim YS, Kim BY, Kwon SW. (2010). Acinetobacter brisouii sp. nov., isolated from a wetland in Korea. J Microbiol, 48, 36-39.
5. Audureau A. (1940). Etude du genre Moraxella. Ann Inst Pasteur, 64, 126-166.
6. Baumann P, Doudorof M, Stanier RY. (1968). A study of the Moraxella group. II. Oxidative-negative species (genus Acinetobacter). J Bacteriol, 95, 1520-1541.
7. Beceiro A, Dominguez L, Ribera A, Vila J, Molina F, Villanueva R, Eiros JM, Bou G. (2004). Molecular characterization of the gene encoding a new AmpC β-lactamase in a clinical strain of Acinetobacter genomic species 3. Antimicrob Agents Chemother, 48, 1374-1378. (Pubitemid 38405499)
8. Beceiro A, Pérez-Llarena FJ, Pérez A, Tomás Mdel M, Fernández A, Mallo S, Villanueva R, Bou G. (2007). Molecular characterization of the gene encoding a new AmpC β-lactamase in Acinetobacter baylyi. J Antimicrob Chemother, 59, 996-1000. (Pubitemid 47073373)
9. Beceiro A, Pérez A, Fernández-Cuenca F, Martínez-Martínez L, Pascual A, Vila J, Rodríguez- Baño J, Cisneros JM, Pachón J, Bou G; and the Spanish Group for Nosocomial Infection (GEIH). (2009). Genetic variability among ampC genes from Acinetobacter genomic species 3. Antimicrob Agents Chemother, 53, 1177-1184.
10. Beijerinck MW. (1911). Pigments as products of oxidation by bacterial action. Proc Royal Acad Sci 13, 1066-1077.
11. Berlau J, Aucken HM, Houang E, Pitt TL. (1999a). Isolation of Acinetobacter spp. including A. baumannii from vegetables: implications for hospital-acquired infections. J Hosp Infect, 42, 201-204. (Pubitemid 29353735)
12. Berlau J, Aucken H, Malnick H, Pitt T. (1999b). Distribution of Acinetobacter species on skin of healthy humans. Eur J Clin Microbiol Infect Dis, 18, 179-183. (Pubitemid 29527951)
13. Bertini A, Poirel L, Bernabeu S, Fortini D, Villa L, Nordmann P, Carattoli A. (2007). Multicopy blaOXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother, 51, 2324-2328. (Pubitemid 47047306)
14. Bertini A, Poirel L, Mugnier PD, Villa L, Nordmann P, Carattoli A. (2010). Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother, 54, 4168-4177.
15. Bogaerts P, Cuzon G, Naas T, Bauraing C, Deplano A, Lissoir B, Nordmann P, Glupczynski Y. (2008). Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium. Antimicrob Agents Chemother, 52, 4205-4206.
16. Bogaerts P, Naas T, El Garch F, Cuzon G, Deplano A, Delaire T, Huang TD, Lissoir B, Nordmann P, Glupczynski Y. (2010). GES extended-spectrum ß-lactamases in Acinetobacter baumannii isolates in Belgium. Antimicrob Agents Chemother, 54, 4872-4878.
17. Bonnet R, Marchandin H, Chanal C, Sirot D, Labia R, De Champs C, Jumas-Bilak E, Sirot J. (2002). Chromosome-encoded class D β-lactamase OXA-23 in Proteus mirabilis. Antimicrob Agents Chemother, 46, 2004-2006. (Pubitemid 34535232)
18. Bonnin RA, Potron A, Poirel L, Lecuyer H, Neri R, Nordmann P. (2011a). PER-7, an extended-spectrum β-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumannii. Antimicrob Agents Chemother, 55, 2424-2427.
19. Bonnin RA, Nordmann P, Potron A, Lecuyer H, Zahar JR, Poirel L. (2011b). Carbapenem-hydrolyzing GES-type extended-spectrum β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother, 55, 349-354.
20. Bou G, Martínez-Beltrán J. (2000). Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother, 44, 428-432. (Pubitemid 30060746)
21. Bou G, Oliver A, Martínez-Beltrán J. (2000). OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother, 44, 1556-1561. (Pubitemid 30340794)
22. Bouvet PJ, Grimont PA. (1986). Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov., and emended description of Acinetobacter calcoaceticus and Acinetobacter lwofi. Int J Syst Bacteriol, 36, 228-240. (Pubitemid 16111528)
23. Bouvet PJ, Jeanjean S. (1989). Delineation of new proteolytic genomic species in the genus Acinetobacter. Res Microbiol, 140, 291-299. (Pubitemid 19207208)
24. Bradford PA. (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev, 14, 933-951. (Pubitemid 32979636)
25. Brisou J, Prevot AR. (1954). [Studies on bacterial taxonomy. X. The revision of species under Acromobacter group]. Ann Inst Pasteur (Paris), 86, 722-728.
26. Brown S, Amyes SG. (2005). The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents. Clin Microbiol Infect, 11, 326-329.
27. Brown S, Young HK, Amyes SG. (2005). Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect, 11, 15-23. (Pubitemid 40227817)
28. Burman LG, Park JT, Lindström EB, Boman HG. (1973). Resistance of Escherichia coli to penicillins: identifcation of the structural gene for the chromosomal penicillinase. J Bacteriol, 116, 123-130.
29. Carr EL, Kämpfer P, Patel BK, Gürtler V, Seviour RJ. (2003). Seven novel species of Acinetobacter isolated from activated sludge. Int J Syst Evol Microbiol, 53, 953-963. (Pubitemid 36896498)
30. Celenza G, Pellegrini C, Caccamo M, Segatore B, Amicosante G, Perilli M. (2006). Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals. J Antimicrob Chemother, 57, 975-978.
31. Chen TL, Lee YT, Kuo SC, Hsueh PR, Chang FY, Siu LK, Ko WC, Fung CP. (2010). Emergence and Distribution of Plasmids Bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan. Antimicrob Agents Chemother, 54, 4575-4581.
32. Choury D, Szajnert MF, Joly-Guillou ML, Azibi K, Delpech M, Paul G. (2000). Nucleotide sequence of the blaRTG-2 (CARB-5) gene and phylogeny of a new group of carbenicillinases. Antimicrob Agents Chemother, 44, 1070-1074. (Pubitemid 30165294)
33. Chu YW, Afzal-Shah M, Houang ET. Palepou MI, Lyon DJ, Woodford N, Livermore DM. (2001). IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother, 45, 710-714. (Pubitemid 32182013)
34. Chu YW, Cheung TK, Chu MY, Lo JY, Dijkshoorn L. (2009). OXA-23-type imipenem resistance in Acinetobacter baumannii in Hong Kong. Int J Antimicrob Agents, 34, 285-286.
35. Corvec S, Carof N, Espaze E, Giraudeau C, Drugeon H, Reynaud A. (2003). AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J Antimicrob Chemother, 52, 629-635. (Pubitemid 37258424)
36. Corvec S, Poirel L, Naas T, Drugeon H, Nordmann P. (2007). Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother, 51, 1530-1533. (Pubitemid 46586845)
37. Da Silva GJ, Correia M, Vital C, Ribeiro G, Sousa JC, Leitão R, Peixe L, Duarte A. (2002). Molecular characterization of blaIMP-5, a new integron-borne metallo-β-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. FEMS Microbiol Lett, 215, 33-39. (Pubitemid 35232579)
38. Datta N, Kontomichalou P. (1965). Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature, 208, 239-241.
39. Dent LL, Marshall DR, Pratap S, Hulette RB. (2010). Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis, 10, 196.
40. Devaud M, Kayser FH, Bächi B. (1982). Transposon-mediated multiple antibiotic resistance in Acinetobacter strains. Antimicrob Agents Chemother, 22, 323-329. (Pubitemid 12020128)
41. Di Cello F, Pepi M, Baldi F, Fani R. (1997). Molecular characterization of an n-alkane-degrading bacterial community and identifcation of a new species, Acinetobacter venetianus. Res Microbiol, 148, 237-249. (Pubitemid 27142197)
42. Dijkshoorn L, Nemec A, Seifert H. (2007). An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol, 5, 939-951. (Pubitemid 350131182)
43. Donald HM, Scaife W, Amyes SG, Young HK. (2000). Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob Agents Chemother, 44, 196-199. (Pubitemid 30010698)
44. Endimiani A, Luzzaro F, Migliavacca R, Mantengoli E, Hujer AM, Hujer KM, Pagani L, Bonomo RA, Rossolini GM, Toniolo A. (2007). Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum β-lactamase. Antimicrob Agents Chemother, 51, 2211-2214. (Pubitemid 46903120)
45. Espinal P, Fugazza G, López Y, Kasma M, Lerman Y, Malhotra-Kumar S, Goosens H, Carmeli Y, Vila J. (2011). Dissemination of the NDM-2-producing Acinetobacter baumannii clone in an Israeli Rehabilitation Center. Antimicrob Agents Chemother (Epub ahead of print).
46. Evans BA, Brown S, Hamouda A, Findlay J, Amyes SG. (2007). Eleven novel OXA-51-like enzymes from clinical isolates of Acinetobacter baumannii. Clin Microbiol Infect, 13, 1137-1138. (Pubitemid 47543118)
47. Evans BA, Hamouda A, Towner KJ, Amyes SG. (2010). Novel genetic context of multiple blaOXA-58 genes in Acinetobacter genospecies 3. J Antimicrob Chemother, 65, 1586-1588.
48. Figueiredo S, Poirel L, Papa A, Koulourida V, Nordmann P. (2008). First identifcation of VIM-4 metallo-β-lactamase in Acinetobacter spp. Clin Microbiol Infect, 14, 289-290. (Pubitemid 351209266)
49. Figueiredo S, Poirel L, Papa A, Koulourida V, Nordmann P. (2009). Overexpression of the naturally occurring blaOXA-51 gene in Acinetobacter baumannii mediated by novel insertion sequence ISAba9. Antimicrob Agents Chemother, 53, 4045-4047.
50. Figueiredo S, Poirel L, Seifert H, Mugnier P, Benhamou D, Nordmann P. (2010). OXA-134, a naturally occurring carbapenem-hydrolyzing class D β-lactamase from Acinetobacter lwofi. Antimicrob Agents Chemother, 54, 5372-5375.
51. Gales AC, Tognim MC, Reis AO, Jones RN, Sader HS. (2003). Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital. Diagn Microbiol Infect Dis, 45, 77-79. (Pubitemid 36165034)
52. Gerner-Smidt P, Tjernberg I, Ursing J. (1991). Reliability of phenotypic tests for identifcation of Acinetobacter species. J Clin Microbiol, 29, 277-282.
53. Gerner-Smidt P, Tjernberg I. (1993). Acinetobacter in Denmark: II. Molecular studies of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. APMIS, 101, 826-832. (Pubitemid 24053931)
54. Giannouli M, Tomasone F, Agodi A, Vahaboglu H, Daoud Z, Triassi M, Tsakris A, Zarrilli R. (2009). Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals. J Antimicrob Chemother, 63, 828-830.
55. Goldstein FW, Labigne-Roussel A, Gerbaud G, Carlier C, Collatz E, Courvalin P. (1983). Transferable plasmid-mediated antibiotic resistance in Acinetobacter. Plasmid, 10, 138-147. (Pubitemid 14233289)
56. Gulati A, Vyas P, Rahi P, Kasana RC. (2009). Plant growth-promoting and rhizosphere-competent Acinetobacter rhizosphaerae strain BIHB 723 from the cold deserts of the Himalayas. Curr Microbiol, 58, 371-377.
57. Hansson K, Sundström L, Pelletier A, Roy PH. (2002). IntI2 integron integrase in Tn7. J Bacteriol, 184, 1712-1721. (Pubitemid 34188223)
58. Henwood CJ, Gatward T, Warner M, James D, Stockdale MW, Spence RP, Towner KJ, Livermore DM, Woodford N. (2002). Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). J Antimicrob Chemother, 49, 479-487. (Pubitemid 34223669)
59. Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H. (2009). OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother, 53, 5035-5038.
60. Houang ET, Chu YW, Leung CM, Chu KY, Berlau J, Ng KC, Cheng AF. (2001). Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong. J Clin Microbiol, 39, 228-234. (Pubitemid 32059596)
61. Huang LY, Lu PL, Chen TL, Chang FY, Fung CP, Siu LK. (2010). Molecular characterization of β-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan. Antimicrob Agents Chemother, 54, 2699-2703.
62. Hujer KM, Hamza NS, Hujer AM, Perez F, Helfand MS, Bethel CR, Tomson JM, Anderson VE, Barlow M, Rice LB, Tenover FC, Bonomo RA. (2005). Identifcation of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 β-lactamase: defning a unique family of class C enzymes. Antimicrob Agents Chemother, 49, 2941-2948. (Pubitemid 40917614)
63. Héritier C, Poirel L, Aubert D, Nordmann P. (2003). Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob Agents Chemother, 47, 268-273. (Pubitemid 36070374)
64. Héritier C, Poirel L, Nordmann P. (2006). Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect, 12, 123-130. (Pubitemid 43379339)
65. Jacoby G, Bush K. (2011). β-Lactamase classifcation and amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant enzymes. http://www.lahey.org/Studies/. Accessed on 3 July 2011.
66. Jacoby GA. (2009). AmpC β-lactamases. Clin Microbiol Rev, 22, 161-182.
67. Kaase M, Nordmann P, Wichelhaus TA, Gatermann SG, Bonnin RA, Poirel L. (2011). NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother, 66, 1260-1262.
68. Kang YS, Jung J, Jeon CO, Park W. (2011). Acinetobacter oleivorans sp. nov. is capable of adhering to and growing on diesel-oil. J Microbiol, 49, 29-34.
69. Karah N, Haldorsen B, Hegstad K, Simonsen GS, Sundsfjord A, Samuelsen Ø; Norwegian Study Group of Acinetobacter. (2011). Species identifcation and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J Antimicrob Chemother, 66, 738-744.
70. Karthikeyan K, Tirunarayan MA, Krishnan P. (2010). Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acineto-bacter baumannii from India. J Antimicrob Chemother, 65, 2253-2254.
71. Kilic A, Li H, Mellmann A, Basustaoglu AC, Kul M, Senses Z, Aydogan H, Stratton CW, Harmsen D, Tang YW. (2008). Acinetobacter septicus sp. nov. association with a nosocomial outbreak of bacteremia in a neonatal intensive care unit. J Clin Microbiol, 46, 902-908. (Pubitemid 351379977)
72. Kim CK, Lee Y, Lee H, Woo GJ, Song W, Kim MN, Lee WG, Jeong SH, Lee K, Chong Y. (2010). Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182. Diagn Microbiol Infect Dis, 68, 432-438.
73. Kim D, Baik KS, Kim MS, Park SC, Kim SS, Rhee MS, Kwak YS, Seong CN. (2008). Acinetobacter soli sp. nov., isolated from forest soil. J Microbiol, 46, 396-401.
74. Koh TH, Sng LH, Wang GC, Hsu LY, Zhao Y. (2007). IMP-4 and OXA β-lactamases in Acinetobacter baumannii from Singapore. J Antimicrob Chemother, 59, 627-632. (Pubitemid 47073394)
75. Lee HJ, Lee SS. (2010). Acinetobacter kyonggiensis sp. nov., a ß-glucosidase-producing bacterium, isolated from sewage treatment plant. J Microbiol, 48, 754-759.
76. Lee K, Kim CK, Hong SG, Choi J, Song S, Koh E, Yong D, Jeong SH, Yum JH, Docquier JD, Rossolini GM, Chong Y. (2010). Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two diferent metallo-β- lactamases. Int J Antimicrob Agents, 36, 259-263.
77. Lee K, Kim MN, Choi TY, Cho SE, Lee S, Whang DH, Yong D, Chong Y, Woodford N, Livermore DM; KONSAR Group. (2009a). Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea. Int J Antimicrob Agents, 33, 520-524.
78. Lee K, Yum JH, Yong D, Lee HM, Kim HD, Docquier JD, Rossolini GM, Chong Y. (2005). Novel acquired metallo-β-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother, 49, 4485-4491. (Pubitemid 41552576)
79. Lee M F, Peng C F, Hsu HJ, Chen YH. (2008). Molecular characterisation of the metallo-β-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan. Int J Antimicrob Agents, 32, 475-480.
80. Lee JS, Lee KC, Kim KK, Hwang IC, Jang C, Kim NG, Yeo WH, Kim BS, Yu YM, Ahn JS. (2009b). Acinetobacter antiviralis sp. nov., from Tobacco plant roots. J Microbiol Biotechnol, 19, 250-256.
81. Lee Y, Kim CK, Lee H, Jeong SH, Yong D, Lee K. (2011). A novel insertion sequence, ISAba10, inserted into ISAba1 adjacent to the blaOXA-23 gene and disrupting the outer membrane protein gene carO in Acinetobacter baumannii. Antimicrob Agents Chemother, 55, 361-363.
82. Lee YT, Turton JF, Chen TL, Wu RC, Chang WC, Fung CP, Chen CP, Cho WL, Huang LY, Siu LK. (2009c). First identifcation of blaOXA-51-like in non-baumannii Acinetobacter spp. J Chemother, 21, 514-520.
83. Lolans K, Rice TW, Munoz-Price LS, Quinn JP. (2006). Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother, 50, 2941-2945. (Pubitemid 44396395)
84. Mahillon J, Chandler M. (1998). Insertion sequences. Microbiol Mol Biol Rev, 62, 725-774. (Pubitemid 28415552)
85. Mammeri H, Poirel L, Mangeney N, Nordmann P. (2003). Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to β-lactams. Antimicrob Agents Chemother, 47, 1536-1542. (Pubitemid 36548534)
86. Marqué S, Poirel L, Héritier C, Brisse S, Blasco MD, Filip R, Coman G, Naas T, Nordmann P. (2005). Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol, 43, 4885-4888. (Pubitemid 41298303)
87. Matthew M, Harris AM. (1976). Identifcation of β-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy. J Gen Microbiol, 94, 55-67.
88. Mazel D. (2006). Integrons: agents of bacterial evolution. Nat Rev Microbiol, 4, 608-620. (Pubitemid 44317023)
89. Mendes RE, Bell JM, Turnidge JD, Castanheira M, Deshpande LM, Jones RN. (2009a). Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother, 53, 843-844.
90. Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN. (2009b). Emergence and widespread dissemination of OXA-23,-24/40 and-58 carbapenemases among Acinetobacter spp. in Asia-Pacifc nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother, 63, 55-59.
91. Merkier AK, Centrón D. (2006). blaOXA-51-type β-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii. Int J Antimicrob Agents, 28, 110-113. (Pubitemid 44108610)
92. Mitsuhashi S, Inoue M. (1981). Mechanisms of resistance to β-lactam antibiotics. In: Mitsuhashi S, ed. β-lactam antibiotics. New York: Springer-Verlag, 41-56.
93. Moubareck C, Brémont S, Conroy MC, Courvalin P, Lambert T. (2009). GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother, 53, 3579-3581.
94. Mugnier PD, Poirel L, Naas T, Nordmann P. (2010). Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerging Infect Dis, 16, 35-40.
95. Mugnier PD, Poirel L, Nordmann P. (2009). Functional analysis of insertion sequence ISAba1, responsible for genomic plasticity of Acinetobacter baumannii. J Bacteriol, 191, 2414-2418.
96. Naas T, Bogaerts P, Bauraing C, Degheldre Y, Glupczynski Y, Nordmann P. (2006a). Emergence of PER and VEB extended-spectrum β-lactamases in Acinetobacter baumannii in Belgium. J Antimicrob Chemother, 58, 178-182. (Pubitemid 44295003)
97. Naas T, Coignard B, Carbonne A, Blanckaert K, Bajolet O, Bernet C, Verdeil X, Astagneau P, Desenclos JC, Nordmann P; French Nosocomial Infection Early Warning Investigation and Surveillance Network. (2006b). VEB-1 Extended-spectrum β-lactamase-producing Acinetobacter baumannii, France. Emerging Infect Dis, 12, 1214-1222.
98. Naas T, Namdari F, Réglier-Poupet H, Poyart C, Nordmann P. (2007). Panresistant extended-spectrum β-lactamase SHV-5-producing Acinetobacter baumannii from New York City. J Antimicrob Chemother, 60, 1174-1176. (Pubitemid 47617776)
99. Naas T, Nordmann P. (1999). OXA-type β-lactamases. Curr Pharm Des, 5, 865-879.
100. Naas T, Poirel L, Nordmann P. (2008). Minor extended-spectrum β-lactamases. Clin Microbiol Infect, 14 Suppl 1, 42-52.
101. Nagano N, Nagano Y, Cordevant C, Shibata N, Arakawa Y. (2004). Nosocomial transmission of CTX-M-2 β-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. J Clin Microbiol, 42, 3978-3984. (Pubitemid 39296113)
102. Naiemi NA, Duim B, Savelkoul PH, Spanjaard L, de Jonge E, Bart A, Vandenbroucke-Grauls CM, de Jong MD. (2005). Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol, 43, 4862-4864. (Pubitemid 41298296)
103. Navia MM, Ruiz J, Vila J. (2002). Characterization of an integron carrying a new class D β-lactamase (OXA-37) in Acinetobacter baumannii. Microb Drug Resist, 8, 261-265. (Pubitemid 36043691)
104. Nemec A, De Baere T, Tjernberg I, Vaneechoutte M, van der Reijden TJ, Dijkshoorn L. (2001). Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol, 51, 1891-1899. (Pubitemid 32899228)
105. Nemec A, Dijkshoorn L, Cleenwerck I, De Baere T, Janssens D, Van Der Reijden TJ, Jezek P, Vaneechoutte M. (2003). Acinetobacter parvus sp. nov., a small-colony-forming species isolated from human clinical specimens. Int J Syst Evol Microbiol, 53, 1563-1567. (Pubitemid 37184991)
106. Nemec A, Musílek M, Maixnerová M, De Baere T, van der Reijden TJ, Vaneechoutte M, Dijkshoorn L. (2009). Acinetobacter beijerinckii sp. nov. and Acinetobacter gyllenbergii sp. nov., haemolytic organisms isolated from humans. Int J Syst Evol Microbiol, 59, 118-124.
107. Nemec A, Musílek M, Sedo O, De Baere T, Maixnerová M, van der Reijden TJ, Zdráhal Z, Vaneechoutte M, Dijkshoorn L. (2010). Acinetobacter bereziniae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate Acinetobacter genomic species 10 and 11, respectively. Int J Syst Evol Microbiol, 60, 896-903.
108. Nemec A, Krizova L, Maixnerova M, van der Reijden TJ, Deschaght P, Passet V, Vaneechoutte M, Brisse S, Dijkshoorn L. (2011). Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol, 162, 393-404.
109. Nishio H, Komatsu M, Shibata N, Shimakawa K, Sueyoshi N, Ura T, Satoh K, Toyokawa M, Nakamura T, Wada Y, Orita T, Kofuku T, Yamasaki K, Sakamoto M, Kinoshita S, Aihara M, Arakawa Y. (2004). Metallo-β-lactamase-producing gram-negative bacilli: laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan. J Clin Microbiol, 42, 5256-5263. (Pubitemid 39506238)
110. Nishimura Y, Ino T, Iizuka H (1988). Acinetobacter radioresistens sp. nov. isolated from cotton and soil. Int J Syst Bacteriol, 38, 209-211.
111. Nordmann P, Guibert M. (1998). Extended-spectrum β-lactamases in Pseudomonas aeruginosa. J Antimicrob Chemother, 42, 128-131.
112. Nordmann P, Mammeri H. (2007). Extended-spectrum cephalosporinases: structure, detection and epidemiology. Future Microbiol, 2, 297-307. (Pubitemid 47180926)
113. Park YK, Choi JY, Jung SI, Park KH, Lee H, Jung DS, Heo ST, Kim SW, Chang HH, Cheong HS, Chung DR, Peck KR, Song JH, Ko KS. (2009). Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals. Diagn Microbiol Infect Dis, 64, 389-395.
114. Paterson DL, Bonomo RA. (2005). Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev, 18, 657-686.
115. Paton R, Miles RS, Hood J, Amyes SG, Miles RS, Amyes SG. (1993). ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents, 2, 81-87.
116. Peleg AY, Franklin C, Walters LJ, Bell JM, Spelman DW. (2006). OXA-58 and IMP-4 carbapenem-hydrolyzing β-lactamases in an Acinetobacter junii blood culture isolate from Australia. Antimicrob Agents Chemother, 50, 399-400. (Pubitemid 43042958)
117. Peleg AY, Seifert H, Paterson DL. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev, 21, 538-582.
118. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. (2007). Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother, 51, 3471-3484. (Pubitemid 47519332)
119. Pfeifer Y, Wilharm G, Zander E, Wichelhaus TA, Göttig S, Hunfeld KP, Seifert H, Witte W, Higgins PG. (2011). Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother, 66, 1998-2001.
120. Poirel L, Corvec S, Rapoport M, Mugnier P, Petroni A, Pasteran F, Faccone D, Galas M, Drugeon H, Cattoir V, Nordmann P. (2007a). Identifcation of the novel narrow-spectrum β-lactamase SCO-1 in Acinetobacter spp. from Argentina. Antimicrob Agents Chemother, 51, 2179-2184. (Pubitemid 46903111)
121. Poirel L, Figueiredo S, Cattoir V, Carattoli A, Nordmann P. (2008a). Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob Agents Chemother, 52, 1252-1256. (Pubitemid 351521984)
122. Poirel L, Mansour W, Bouallegue O, Nordmann P. (2008b). Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97. Antimicrob Agents Chemother, 52, 1613-1617. (Pubitemid 351614650)
123. Poirel L, Marqué S, Héritier C, Segonds C, Chabanon G, Nordmann P. (2005). OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother, 49, 202-208. (Pubitemid 40065794)
124. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. (2003). Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol, 41, 3542-3547. (Pubitemid 36994680)
125. Poirel L, Mugnier PD, Toleman MA, Walsh TR, Rapoport MJ, Petroni A, Nordmann P. (2009). ISCR2, another vehicle for blaVEB gene acquisition. Antimicrob Agents Chemother, 53, 4940-4943.
126. Poirel L, Naas T, Nordmann P. (2010). Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother, 54, 24-38.
127. Poirel L, Nordmann P. (2006). Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother, 50, 1442-1448.
128. Poirel L, Pitout JD, Nordmann P. (2007b). Carbapenemases: molecular diversity and clinical consequences. Future Microbiol, 2, 501-512. (Pubitemid 47578214)
129. Potron A, Poirel L, Croizé J, Chanteperdrix V, Nordmann P. (2009). Genetic and biochemical characterization of the frst extended-spectrum CARB-type β-lactamase, RTG-4, from Acinetobacter baumannii. Antimicrob Agents Chemother, 53, 3010-3016.
130. Queenan AM, Bush K. (2007). Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev, 20, 440-458.
131. Ramirez MS, Adams MD, Bonomo RA, Centrón D, Tolmasky ME. (2011). Genomic analysis of Acinetobacter baumannii A118 by comparison of optical maps: identifcation of structures related to its susceptibility phenotype. Antimicrob Agents Chemother, 55, 1520-1526.
132. Ramírez MS, Piñeiro S, Centrón D; Argentinian Integron Study Group. (2010). Novel insights about class 2 integrons from experimental and genomic epidemiology. Antimicrob Agents Chemother, 54, 699-706.
133. Ravasi P, Limansky AS, Rodriguez RE, Viale AM, Mussi MA. (2011). ISAba825, a functional insertion sequence modulating genomic plasticity and blaOXA-58 expression in Acinetobacter baumannii. Antimicrob Agents Chemother, 55, 917-920.
134. Riccio ML, Franceschini N, Boschi L, Caravelli B, Cornaglia G, Fontana R, Amicosante G, Rossolini GM. (2000). Characterization of the metallo-β-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of blaIMP allelic variants carried by gene cassettes of diferent phylogeny. Antimicrob Agents Chemother, 44, 1229-1235. (Pubitemid 30228299)
135. Robledo IE, Aquino EE, Santé MI, Santana JL, Otero DM, León CF, Vázquez GJ. (2010). Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother, 54, 1354-1357.
136. Rodríguez-Martínez JM, Nordmann P, Ronco E, Poirel L. (2010a). Extended-spectrum cephalosporinase in Acinetobacter baumannii. Antimicrob Agents Chemother, 54, 3484-3488.
137. Rodríguez-Martínez JM, Poirel L, Nordmann P. (2010b). Genetic and functional variability of AmpC-type ß-lactamases from Acinetobacter baumannii. Antimicrob Agents Chemother, 54, 4930-4933.
138. Sato K, Nakae T. (1991). Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. J Antimicrob Chemother, 28, 35-45.
139. Segal H, Garny S, Elisha BG. (2005). Is ISABA-1 customized for Acinetobacter? FEMS Microbiol Lett, 243, 425-429.
140. Segal H, Nelson EC, Elisha BG. (2004). Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate. Antimicrob Agents Chemother, 48, 612-614. (Pubitemid 38141725)
141. Seifert H, Baginski R, Schulze A, Pulverer G. (1993a). The distribution of Acinetobacter species in clinical culture materials. Zentralbl Bakteriol, 279, 544-552. (Pubitemid 2004863)
142. Seifert H, Baginski R, Schulze A, Pulverer G. (1993b). Antimicrobial susceptibility of Acinetobacter species. Antimicrob Agents Chemother, 37, 750-753. (Pubitemid 23096873)
143. Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M. (1997). Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identifcation methods. J Clin Microbiol,
144. Sevillano E, Gallego L, García-Lobo JM. (2009). First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii. Pathol Biol, 57, 493-495.
145. Shakil S, Khan AU. (2010). Detection of CTX-M-15-producing and carbapenem-resistant Acinetobacter baumannii strains from urine from an Indian hospital. J Chemother, 22, 324-327.
146. Shibata N, Doi Y, Yamane K, Yagi T, Kurokawa H, Shibayama K, Kato H, Kai K, Arakawa Y. (2003). PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J Clin Microbiol, 41, 5407-5413. (Pubitemid 37543224)
147. Stokes HW, Hall RM. (1989). A novel family of potentially mobile DNA elements encoding site-specifc gene-integration functions: integrons. Mol Microbiol, 3, 1669-1683. (Pubitemid 20023246)
148. Tian GB, Adams-Haduch JM, Bogdanovich T, Pasculle AW, Quinn JP, Wang HN, Doi Y. (2011a). Identifcation of diverse OXA-40 group carbapenemases, including a novel variant, OXA-160, from Acinetobacter baumannii in Pennsylvania. Antimicrob Agents Chemother, 55, 429-432.
149. Tian GB, Adams-Haduch JM, Taracila M, Bonomo RA, Wang HN, Doi Y. (2011b). Extended-spectrum AmpC in Acinetobacter baumannii; ADC-56 confers resistance to cefepime. Antimicrob Agents Chemother 55, 4922-4925.
150. Tjernberg I, Ursing J. (1989). Clinical strains of Acinetobacter classifed by DNA-DNA hybridization. APMIS, 97, 595-605. (Pubitemid 19188334)
151. Teaker C, Azadian B, Soni N. (2003). The impact of Acinetobacter baumannii in the intensive care unit. Anaesthesia, 58, 271-274. (Pubitemid 36329274)
152. Toleman MA, Simm AM, Murphy TA, Gales AC, Biedenbach DJ, Jones RN, Walsh TR. (2002). Molecular characterization of SPM-1, a novel metallo-β- lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother, 50, 673-679. (Pubitemid 35331684)
153. Towner KJ, Levi K, Vlassiadi M; ARPAC Steering Group. (2008). Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe. Clin Microbiol Infect, 14, 161-167.
154. Tsakris A, Ikonomidis A, Poulou A, Spanakis N, Vrizas D, Diomidous M, Pournaras S, Markou F. (2008). Clusters of imipenem-resistant Acinetobacter baumannii clones producing diferent carbapenemases in an intensive care unit. Clin Microbiol Infect, 14, 588-594. (Pubitemid 351639074)
155. Tsakris A, Ikonomidis A, Pournaras S, Tzouvelekis LS, Sofanou D, Legakis NJ, Maniatis AN. (2006). VIM-1 metallo-β-lactamase in Acinetobacter baumannii. Emerging Infect Dis, 12, 981-983.
156. Tsakris A, Ikonomidis A, Spanakis N, Pournaras S, Bethimouti K. (2007). Identifcation of a novel blaOXA-51 variant, blaOXA-92, from a clinical isolate of Acinetobacter baumannii. Clin Microbiol Infect, 13, 348-349. (Pubitemid 46603375)
157. Turner PJ. (2008). Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results. Diagn Microbiol Infect Dis, 60, 185-192.
158. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL. (2006a). The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett, 258, 72-77.
159. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. (2006b). Identifcation of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol, 44, 2974-2976. (Pubitemid 44228598)
160. Vahaboglu H, Budak F, Kasap M, Gacar G, Torol S, Karadenizli A, Kolayli F, Eroglu C. (2006). High prevalence of OXA-51-type class D β-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres. J Antimicrob Chemother, 58, 537-542. (Pubitemid 44288116)
161. Vahaboglu H, Oztürk R, Aygün G, Coskunkan F, Yaman A, Kaygusuz A, Leblebicioglu H, Balik I, Aydin K, Otkun M. (1997). Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother, 41, 2265-2269. (Pubitemid 27422224)
162. Vaz-Moreira I, Novo A, Hantsis-Zacharov E, Lopes AR, Gomila M, Nunes OC, Manaia CM, Halpern M. (2011). Acinetobacter rudis sp. nov. isolated from raw milk and raw wastewater. Int J Syst Evol Microbiol, (Epub ahead of print).
163. Vila J, Marcos A, Marco F, Abdalla S, Vergara Y, Reig R, Gomez-Lus R, Jimenez de Anta T. (1993). In vitro antimicrobial production of β-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother, 37, 138-141. (Pubitemid 23019187)
164. Vila J, Navia M, Ruiz J, Casals C. (1997). Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother, 41, 2757-2759. (Pubitemid 27524754)
165. Waley SG. (1992). β-Lactamase: mechanism of action. In: Page MI, ed. The chemistry of β-lactams. London: Chapman and Hall, 198-228.
166. Walsh TR, Toleman MA, Poirel L, Nordmann P. (2005). Metallo-β- lactamases: the quiet before the storm? Clin Microbiol Rev, 18, 306-325.
167. Walther-Rasmussen J, Høiby N. (2007). Class A carbapenemases. J Antimicrob Chemother, 60, 470-482. (Pubitemid 47299859)
168. Wang H, Guo P, Sun H, Wang H, Yang Q, Chen M, Xu Y, Zhu Y. (2007). Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother, 51, 4022-4028. (Pubitemid 350057801)
169. Yamamoto M, Nagao M, Matsumura Y, Matsushima A, Ito Y, Takakura 5, Ichiyama S. (2011). Interspecies dissemination of a novel class 1 integron carrying blaIMP-19 among Acinetobacter species in Japan. J Antimicrob Chemother, Epub ahead of print.
170. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. (2009). Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother, 53, 5046-5054.
171. Yoon JH, Kim IG, Oh TK. (2007). Acinetobacter marinus sp. nov. and Acinetobacter seohaensis sp. nov., isolated from sea water of the Yellow Sea in Korea. J Microbiol Biotechnol, 17, 1743-1750.
172. Yum JH, Yi K, Lee H, Yong D, Lee K, Kim JM, Rossolini GM, Chong Y. (2002). Molecular characterization of metallo-β-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identifcation of two new integrons carrying the blaVIM-2 gene cassettes. J Antimicrob Chemother, 49, 837-840. (Pubitemid 34537647)
173. Zarrilli R, Crispino M, Bagattini M, Barretta E, Di Popolo A, Triassi M, Villari P. (2004). Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Microbiol, 42, 946-953. (Pubitemid 38332809)
174. Zhao WH, Hu ZQ. (2010). β-lactamases identifed in clinical isolates of Pseudomonas aeruginosa. Crit Rev Microbiol, 36, 245-258.
175. Zhao WH, Hu ZQ. (2011a). IMP-type metallo-ß-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons. Crit Rev Microbiol, 37, 214-226.
176. Zhao WH, Hu ZQ. (2011b). Epidemiology and genetics of VIM-type metallo-ß-lactamases in Gram-negative bacilli. Future Microbiol, 6, 317-333.
177. Zong Z, Lü X, Valenzuela JK, Partridge SR, Iredell J. (2008). An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China. Int J Antimicrob Agents, 31, 50-54.